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Abstract
Background. Increased neural error-signals have been observed in obsessive-compulsive
disorder (OCD), anxiety disorders, and inconsistently in depression. Reduced neural error-
signals have been observed in substance use disorders (SUD). Thus, alterations in error-
monitoring are proposed as a transdiagnostic endophenotype. To strengthen this notion,
data from unaffected individuals with a family history for the respective disorders are needed.
Methods. The error-related negativity (ERN) as a neural indicator of error-monitoring was
measured during a flanker task from 117 OCD patients, 50 unaffected first-degree relatives of
OCD patients, and 130 healthy comparison participants. Family history information indicated,
that 76 healthy controls were free of a family history for psychopathology, whereas the remain-
ing had first-degree relatives with depression (n = 28), anxiety (n = 27), and/or SUD (n = 27).
Results. Increased ERN amplitudes were found in OCD patients and unaffected first-degree
relatives of OCD patients. In addition, unaffected first-degree relatives of individuals with anx-
iety disorders were also characterized by increased ERN amplitudes, whereas relatives of indi-
viduals with SUD showed reduced amplitudes.
Conclusions. Alterations in neural error-signals in unaffected first-degree relatives with a fam-
ily history of OCD, anxiety, or SUD support the utility of the ERN as a transdiagnostic endo-
phenotype. Reduced neural error-signals may indicate vulnerability for under-controlled
behavior and risk for substance use, whereas a harm- or error-avoidant response style and
vulnerability for OCD and anxiety appears to be associated with increased ERN. This adds
to findings suggesting a common neurobiological substrate across psychiatric disorders involv-
ing the anterior cingulate cortex and deficits in cognitive control.
Introduction
Obsessive-compulsive disorder (OCD) is characterized by intrusive obsessions and repetitive
compulsions. The lifetime prevalence is estimated to be 1–3% (Ruscio et al., 2010). Despite
its prevalence and its impact on life quality, the pathophysiology of OCD is not well under-
stood. Further, despite accumulating evidence for heritability of OCD and associated traits
(Pauls et al., 2014), reliable evidence for the involvement of specific genes has not emerged
(Pauls et al., 2014; International Obsessive Compulsive Disorder Foundation Genetics and
Studies, 2017). OCD is etiologically complex, with multiple genetic, epigenetic, and environ-
mental factors as well as their interactions contributing to its development (Pauls et al., 2014).
Phenotypic heterogeneity, overlap in symptoms, and high comorbidity between psychiatric
disorders (Insel et al., 2010; Ruscio et al., 2010) further complicate research and it remains
a major scientific challenge to unravel the etiology of complex disorders such as OCD. The
Research Domain Criteria (RDoC) initiative and the endophenotype concept are hoped to
help overcoming these problems (Gottesman and Gould, 2003; Insel et al., 2010; Miller and
Rockstroh, 2013). RDoC takes a transdiagnostic perspective and conceptualizes psychopath-
ology with a stronger grounding in neuroscience and in relation to dysfunctions in fundamen-
tal dimensions of behavior and neurobiology (Insel et al., 2010). Endophenotypes are heritable
biological or psychological traits that represent simpler signs to etiological underpinnings and
are assumed to be closer to genes and disease mechanisms (Gottesman and Gould, 2003; Insel
et al., 2010; Miller and Rockstroh, 2013). Both concepts consistently emphasize a grounding in
neuroscience, a focus on disease mechanisms, and transdiagnostic processes (Miller and
Rockstroh, 2013).
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Neural error-signals are a promising research target within
both concepts, and alterations in error-processing are suggested
to play a role in several mental disorders. The error-related nega-
tivity (ERN) is a well-validated and established electrophysio-
logical marker of error-processing. The ERN is a negative
deflection in the event-related brain potential peaking over
fronto-central electrodes following an error and has been asso-
ciated with activity in the midcingulate cortex predominantly
the anterior cingulate cortex (ACC; Debener et al., 2005;
Manoach and Agam, 2013; Grutzmann et al., 2016).†1 The ERN
has been repeatedly found to be increased in OCD patients
(Endrass and Ullsperger, 2014; Riesel, 2019) and fulfills key cri-
teria for an endophenotype (Gottesman and Gould, 2003; Miller
and Rockstroh, 2013), including heritability (Anokhin et al.,
2008), and a robust association with the disorder (Endrass and
Ullsperger, 2014; Riesel, 2019). Furthermore, increased ERN
amplitudes persist after symptom reduction over the course of
cognitive behavioral therapy (CBT, Hajcak et al., 2008; Huyser
et al., 2011; Riesel et al., 2015) and are also observed in unaffected
first-degree relatives of OCD patients in the absence of symptoms
(Riesel et al., 2011; Carrasco et al., 2013). Altogether, these results
highlight that increased ERN amplitudes seem not to be the con-
sequence or a correlate of OCD symptoms but to rather represent
a promising endophenotype reflecting vulnerability for the
disorder.
However, increased ERN amplitudes are not specific to OCD.
Hyperactive neural error-signals in the brain have been linked to
worry (Moser et al., 2013), repetitive behavior (Manoach and
Agam, 2013), checking (Weinberg et al., 2015b), and anxiety
proneness (Cavanagh and Shackman, 2014), symptoms that
represent core features of OCD but are shared with other disor-
ders. In the same vein, increased ERN amplitudes are not specific
to OCD but have also been observed in generalized anxiety dis-
order (GAD), social anxiety, health anxiety, and less consistently
in depression (Manoach and Agam, 2013; Endrass et al., 2014;
Weinberg et al., 2015a; Gillan et al., 2017; Riesel et al., 2017).
Moreover, increased amplitudes prospectively predict the devel-
opment of anxiety symptoms (Lahat et al., 2014; Lamm et al.,
2014; Meyer et al., 2015; Meyer et al., 2018). In contrast, reduced
ERN amplitudes have been found in schizophrenia, bipolar dis-
order (Minzenberg et al., 2014), substance use disorder (SUD)
and, inconsistently, in autism and attention-deficit/hyperactivity
disorder (Manoach and Agam, 2013; Luijten et al., 2014; Gillan
et al., 2017). In schizophrenia and SUD, results from a treatment
study and high-risk populations indicate that error-processing
deficits precede illness onset (Simmonite et al., 2012; Euser
et al., 2013; Manoach and Agam, 2013; Gillan et al., 2017).
Against this background, error-related brain activity qualifies as
a promising transdiagnostic endophenotype with both reduction
and enhancement in neural error-signals each indicating vulner-
ability for different types of psychopathology. To further
strengthen this notion, studies examining unaffected first-degree
relatives are of crucial importance given that family history is a
major risk-factor for the development of psychopathology. The
current study aims to replicate the finding that OCD patients
and their unaffected first-degree relatives show increased ERN
amplitudes. Moreover, we investigate whether alterations in neural
error-signals reflect vulnerability across diagnoses by examining
unaffected first-degree relatives of individuals with anxiety
disorders, depression, and SUD. We hypothesize that individuals
with familial risk for anxiety show increased ERN amplitudes,
whereas those at risk for SUD show reduced amplitudes.
Methods
Participants
One hundred and seventeen patients with OCD, 50 unaffected
first-degree relatives of patients with OCD (parents: n = 34, sib-
lings: n = 13, offspring: n = 3), and 130 healthy comparison parti-
cipants without a family history of OCD participated in the study
(see Table 1). All participants were examined by trained clinical
psychologists using the Structured Clinical Interview for
Diagnostic and Statistical Manual of Mental Disorders (DSM)-
IV (SCID, First et al., 1996) to assess past and present psychiatric
disorders. For all participants family history information of psy-
chopathology for their first-degree relatives was collected using
the Family History Screen (Weissman et al., 2000), a structured
interview that assesses all major DSM-IV diagnoses. Of the 130
healthy comparison participants, 76 were free of any family his-
tory for psychopathology (i.e. none of their first-degree relatives
fulfilled criteria for a major DSM diagnosis), whereas the remain-
ing reported a family history of depression (unaffected first-degree
relatives of individuals with depression, n = 28), anxiety disorders
(unaffected first-degree relatives of individuals with anxiety disor-
ders, n = 27), and/or SUD (unaffected first-degree relatives of indi-
viduals with SUD, n = 27)2. All participants were between 18 and
65 years of age, had normal or corrected-to-normal vision, and
reported no history of neurological disease or head trauma.
Details about the subject flow and dropout reasons are presented
in the supplementary information (online Supplementary Fig. 1).
OCD patients were recruited via the outpatient clinic at
Humboldt-Universität zu Berlin, Germany, and fulfilled criteria
for OCD as verified with the SCID. Exclusion criteria for patients
were: a current or lifetime diagnosis of psychotic, SUD, or bipolar
disorders as well as neuroleptic medication in the past 4 weeks
and/or benzodiazepines use in the past 2 weeks. Fifty OCD
patients were currently taking psychotropic medication (serotonin
reuptake inhibitors: n = 38, serotonin–norepinephrine reuptake
inhibitors: n = 6, tricyclic antidepressants: n = 6). The majority
of patients had one to three comorbid axis-I disorders: major
depression (n = 27 remitted, n = 31 current episode), dysthymia
(n = 10), panic disorder (n = 3), agoraphobia (n = 2), social phobia
(n = 10), specific phobia (n = 10), GAD (n = 5), unspecific somato-
form disorder (n = 6), pain disorder (n = 1), hypochondria (n = 1),
body dysmorphic disorder (n = 1), anorexia nervosa (n = 1),
binge eating disorder (n = 2), tic disorder (n = 6), excoriation dis-
order (n = 1).
First-degree relatives of patients with OCD were recruited via
OCD patients that were diagnosed and treated at the outpatient
clinic at Humboldt-Universität zu Berlin. OCD patients gave writ-
ten informed consent for contacting them. For all first-degree
relatives of OCD patients the diagnosis of their affected relative
was verified in a face-to-face SCID. OCD relatives were only
included if they themselves were free of past or present OCD.
Additional exclusion criteria applied to unaffected first-degree
relatives of OCD patients were: lifetime diagnosis of psychotic,
bipolar, or SUD, and psychotropic medication in the past 4 weeks.
Healthy comparison participants were recruited via public adver-
tisements and were matched for age, gender, and education level to
OCD patients. Exclusion criteria for comparison participants were†The notes appear after the main text.
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as follows: psychoactive medication in the past 3 months; any cur-
rent or past axis-I disorder; and a family history of OCD. The
Family History Screen (Weissman et al., 2000) indicated that 28
healthy participants had first-degree relatives with depression, 27
first-degree relatives with anxiety disorders, and/or 27 reported to
have first-degree relatives with SUD. Thus, the effects of a family
history for depression, SUD (alcohol and substance use), and anx-
iety disorders (GAD, specific phobia, social phobia, agoraphobia,
panic disorder) were examined. The number of cases did not
allow to examine familial risk for other disorder such as schizophre-
nia, or attention-deficit/hyperactivity disorder or to separately ana-
lyze different anxiety disorders with sufficient power2. Note that
family history information for unaffected first-degree relatives of
individuals with SUD, anxiety, or depression was not verified by a
direct interview with the family members but was derived via the
Family History Screen (Weissman et al., 2000).
All participants gave written informed consent after receiving
written and verbal information about the study, and were monetarily
compensated for their time. The study was conducted in accordance
with the ethical guidelines of the revised Declaration of Helsinki, as
confirmed by the ethics committee of Humboldt-Universität zu
Berlin.
Measures
All participants completed the Beck-Depression-Inventory II (Beck
et al., 1996), the Obsessive-Compulsive Inventory-Revised (Foa
et al., 2002), and the State-Trait Anxiety Inventory (STAI,
Spielberger et al., 1983) to assess self-reported severity of depres-
sive, obsessive-compulsive, and anxiety symptoms, respectively.
The Obsessive-Compulsive Trait Core Dimensions Questionnaire
(Ecker and Gonner, 2008) was used to assess harm avoidance
and sense of incompleteness in the participants. The
Wortschatztest (Schmidt and Metzler, 1992) was applied to meas-
ure verbal intelligence. In addition, for patients only, severity of
obsessive-compulsive and depressive symptoms was rated by









Statistic pMean s.d. Mean s.d. Mean s.d.
Demographical data
N 117 50 130
Mean age, years 31.9 9.4 45 14.8 32.1 9.9 F(2, 294) = 30.22 0.00
Gender (% female) 53 64 58 χ2(2) = 1.79 0.41
Verbal IQ 103.2 10 106.5 9.6 104.8 9.4 F(2, 294) = 2.17 0.12
Family history
Depressive disorders n in % 45.3 54 21.5 χ2(2) = 30.44 <0.001
SUD n in % 19.7 14 20.8 χ2(2) = 17.70 <0.001
Anxiety disorders n in % 43.6 42 20.8 χ2(2) = 17.70 <0.001
Clinical data
Obsessive-compulsive inventory-revised 27.32 12.17 5.78 6.12 3.85 3.87 F(2,294) = 261.82 <0.001
Beck depression inventory-II 18.81 10.70 3.46 4.38 2.53 3.32 F(2,294) = 169.30 <0.001
State-trait-anxiety-inventory traita 53.12 10.34 33.58 7.52 32.19 7.54 F(2,288) = 191.21 <0.001
Harm avoidant motivation (OC-TCDQ)a 9.92 3.52 2.82 2.18 2.24 1.89 F(2,288) = 271.80 <0.001
Sense of incompleteness (OC-TCDQ)a 15.20 5.40 5.08 3.79 4.39 3.27 F(2,288) = 211.28 <0.001
Yale-brown obsessive-compulsive scaleb 23.27 9.49
Montgomery-Asberg depression rating scaleb 13.23 9.24
Age of onsetb 23.27 9.49
Performance datac
Error rate in % 4.41 3.42 3.44 2.97 4.33 3.26 F(2287) = 0.04 0.97
Reaction time for correct trials 436 48 462 54 438 48
F(2287) = 0.18 0.84
Reaction time for errors 371 76 385 66 373 56
Robust post-error slowing 40 45 52 60 39 47 F(2287) = 0.28 0.76
S.D., standard deviation; OCD, obsessive-compulsive disorder; IQ, intelligence quotient; SUD, substance use disorders; OC-TCDQ, Obsessive-Compulsive Trait Core Dimensions Questionnaire.
aState-Trait-Anxiety-Inventory and OC-TCDQ scores were missing for six OCD patients.
bYale-Brown Obsessive-Compulsive Scale, Montgomery-Asberg Depression Rating Scale and age of onset were only applicable in patients.
cFor performance data, age was included as a covariate to account for group differences. Further, performance data of six participants were missing due to technical problems (n = 2 OCD
patients, n = 2 relatives, and n = 2 healthy comparison participants).
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trained clinicians using the Yale-Brown Obsessive-Compulsive
Scale (Goodman et al., 1989) and the Montgomery-Asberg
Depression Rating Scale (Montgomery and Asberg, 1979).
Task
An arrow-version of the flanker task was administered using
Presentation software (Neurobehavioral Systems, Inc., Albany,
California). On each trial, five vertically aligned arrows were pre-
sented and participants were instructed to indicate the direction of
the central arrow. The stimuli were presented for 100 ms, followed
by a 1000 ms response interval, followed by an inter-trial interval
that varied randomly between 200 and 1200 ms. Half of the trials
were congruent and half were incongruent. Eight blocks with 60
trials and at the beginning 20 practice trials were presented. After
each block, participants were reminded to respond both quickly
and accurately. The duration of the experiment was about 25 min.
Electroencephalographic recording and analyses
The electroencephalogram (EEG) was recorded from 61 Ag/
AgCl-electrodes using an equidistant electrode montage
(EASYCAP GmbH, Herrsching-Breitbrunn, Germany). External
electrodes were placed below the eyes, below T1 (ground), and
on the nasion. Channels were referenced to Cz during recording
and impedances were below 5 kΩ. The EEG was sampled at a
rate of 1000 Hz and a resolution of 0.1 µV. EEG data were pro-
cessed offline using BrainVision Analyzer 2.1 (Brain Products
GmbH, Munich, Germany). The following filters were applied:
a 50 Hz notch filter, a 30 Hz low-pass filter, and a 0.01 Hz high-
pass filter. To correct for eye movements and eye blinks, an ocular
correction independent component analysis was conducted. Data
were re-referenced to average reference and response-locked seg-
ments were computed from 400 ms before and 1000 ms after
response execution (baseline-correction −100 to 0 ms). Artifacts
were excluded based on the following criteria: amplitude changes
exceeding 50 µV between consecutive data points, voltage differ-
ences of more than 200 µV within a 200 ms interval, and voltage
changes of less than 0.50 µV within a 100 ms interval. Only par-
ticipants with at least six artifact-free error trials were analyzed to
ensure a reliable quantification of ERN (Olvet and Hajcak, 2009).
ERN and CRN were quantified as the difference between the most
negative peak occurring in a 150 ms post-response epoch and the
immediately preceding positive peak at electrode FCz where
error-related brain activity was maximal (Riesel et al., 2011). In
addition, we also calculated ΔERN (ERN minus CRN) and quan-
tified the ERN and CRN as the mean amplitude centered around
the most negative peak occurring in a 150 ms epoch following the
response at electrode FCz (peak ± 20 ms). Note that the pattern of
results was replicated across the different ERN quantifications and
related results are reported in online Supplementary information
(SI 2). Results for the CRN are presented in the online
Supplementary information (SI 1).
Statistical analyses
One-way analyses of covariance were used to examine differences
in ERN, symptom severity, and error rate between OCD patients,
OCD relatives and healthy participants. Repeated-measurement
analyses of covariance were used to analyze response times
including group (OCD patients, OCD relatives, and healthy com-
parison participants) as between-subjects and response type
(correct, error) as within-subjects factors. Age was included as a cov-
ariate in these analyses to control for age differences between
groups. Additional analyses for the OCD group includedmedication
(with n = 50, without medication n = 66) and comorbidity (with n =
86, without comorbidity n = 31) as between-subjects factors. We
used hierarchical regressions to examine whether family history
explained variance in ERN in unaffected comparison participants.
Results for the CRN and the whole sample are presented in the
online Supplementary information (SI 1 and SI 3). In a first step,
the effects of age, depressive, and obsessive-compulsive symptoms
were controlled. In a second step, family history information for
SUD, depression, and anxiety was entered. In a third step, interac-
tions between familial risk statuses were included. Regression and
correlational analyses were performed to determine the relation
between ERN and symptoms (online Supplementary information
SI 4). Heritability estimates for error-related brain activity were com-
puted using Sequential Oligogenic Linkage Analysis Routines
(SOLAR) and are presented in the online Supplementary informa-
tion (SI 5). All statistical tests were two-tailed with α = 0.05.
Post-hoc comparisons were corrected using the Bonferroni proced-
ure. Statistical analyses were conducted with SPSS (Version 21.0,
Chicago, USA).
Results
Demographic and behavioral data
Table 1 shows demographic, clinical, behavioral measures, and the
statistics for the comparison between groups. Patients with OCD
and healthy comparison participants did not differ in age (t245 =
0.14, p = 0.89). OCD relatives were significantly older compared to
patients (t165 = 6.82, p < 0.001) and healthy comparison partici-
pants (t178 = 6.71, p < 0.001). Groups did not differ in gender
and verbal intelligence quotient (IQ). OCD patients scored higher
on symptom measures than OCD relatives (depressive symptoms:
t165 = 9.78, p < 0.001; obsessive-compulsive symptoms: t165 =
11.87, p < 0.001; anxiety symptoms: t159 = 12.00, p < 0.001; harm
avoidance: t159 = 13.16, p < 0.001; sense of incompleteness: t159 =
11.98, p < 0.001) and healthy comparison participants (depressive
symptoms: t245 = 16.47, p < 0.001; obsessive-compulsive symptoms:
t245 = 20.85, p < 0.001; anxiety symptoms: t239 = 18.12, p < 0.001;
harm avoidance: t239 = 21.48, p < 0.001; sense of incompleteness:
t239 = 19.10, p < 0.001). OCD relatives did not differ from healthy
comparison participants in depressive (t178 = 1.52, p = 0.13), anx-
iety symptoms (t178 = 1.11, p = 0.27), harm avoidance (t178 = 1.74,
p = 0.08) and sense of incompleteness (t178 = 1.21, p = 0.23).
However, unaffected first-degree relatives reported slightly more
obsessive-compulsive symptoms (t178 = 2.51, p = 0.01).
Groups did not differ in error rates. Correct responses were
slower compared to errors (F1,287 = 28.31, p < 0.001, η
2
P = 0.09).
A main effect of the covariate age (F1,287 = 52.47, p < 0.001,
η2P = 0.16) reflected that increasing age was associated with slower
responses (r = 0.49, p < 0.001). No main effect of group was
observed after accounting for age differences. Robust post-error
slowing (difference in reaction time between post-error and the
associated pre-error trial) did not differ between groups.
Error-related negativity
Figure 1 displays ERN for OCD patients, unaffected first-degree
relatives of OCD patients and unaffected comparison participants.
Results for the CRN are presented in the online Supplementary
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information (SI 1). A significant main effect of group (F2,293 = 4.39,
p = 0.005, η2P = 0.04, d = 0.39) was observed. Both OCD patients
and unaffected relatives of OCD patients showed enhanced ERN
amplitudes compared to unaffected comparison participants
[OCD patients v. healthy comparison participants: mean difference
= 1.39, s.e. = 0.59, p = 0.05, 95% confidence interval (CI) (0.04–
2.80); OCD relatives v. healthy comparison participants: mean dif-
ference = 2.49, s.e. = 0.83, p = 0.009, 95% CI (0.48–4.50)]. OCD
patients and OCD relatives did not differ in ERN [mean difference
= 0.19, S.E. = 0.81, p = 0.81, 95% CI (−1.40 to 1.79)]. A significant
main effect of the covariate age (F1,293 = 7.85, p = 0.005, η
2
P =
0.03) was observed. Age and ERN showed a positive correlation
(r = 0.12; p = 0.05) with increasing age being associated with
more positive (i.e. smaller) amplitudes. For patients, neither a
main effect for medication (F1,114 = 0.02, p = 0.89, η
2
P = 0.00), or
comorbidity (F1,114 = 0.44, p = 0.51, η
2
P = 0.004) nor significant
interactions involving these variables were observed ( p values
>0.33). When analyzing associations with symptoms across the
whole sample, only harm avoidance showed a correlation with
ERN (r =−0.13, p = 0.03). Higher harm avoidant motivation was
associated with more negative, i.e. larger amplitudes. No other asso-
ciations with symptoms or verbal IQ in the whole sample as well as
symptom dimensions and clinical features in OCD patients were
observed (see online Supplementary information SI 4).
Using hierarchical regressions, we examined whether family
history information explained variance in ERN in healthy com-
parison participants after adjusting for age, gender and symptom
severity (Table 2, Fig. 2). Familial risk for SUD and anxiety
(i.e. having a first-degree relative with this disorder) significantly
predicted ERN magnitude in healthy participants. Unaffected
first-degree relatives of individuals with SUD (i.e. healthy partici-
pants at familial risk for SUD) reported lower ERN amplitudes
compared to those without familial risk for SUD [t128 = 2.49,
p = 0.01, d = 0.54, mean difference = 2.40, S.E. = 0.96, 95% CI
(0.49–4.30)]. Further, increased ERN amplitudes were observed
in unaffected first-degree relatives of individuals with anxiety
[i.e. healthy participants with a family history for anxiety;
t128 = 2.83, p = 0.005, d = 0.61, mean difference = 2.70, S.E. = 0.96,
95% CI (0.81–4.59)]. Unaffected first-degree relatives of indivi-
duals with anxiety disorder (M =−10.37, S.D. = 5.66) did not differ
in ERN from OCD patients (M = −9.62, s.d. = 4.58) and OCD
relatives (M = −9.82, s.d. = 5.22; F2,190 = 0.72, p = 0.49, η2P =
0.008). Entering interactions between risk statuses does not sig-
nificantly enhance the model fit (change in F = 0.75) and no sig-
nificant interactions were observed.
Discussion
Neural error-signals were examined as an endophenotype for
OCD by comparing it between patients with OCD, unaffected
first-degree relatives of OCD patients and healthy participants
without a family history for OCD. Furthermore, we evaluated
whether neural error-signals may represent a transdiagnostic
endophenotype by analyzing unaffected first-degree relatives of
individuals with SUD, depression, and anxiety disorders. Three
main findings were observed: first, both patients with OCD and
Fig. 1. (a) Grand average waveforms at electrode site FCz for ERN amplitude in OCD patients (red lines, N = 117), unaffected first-degree relatives of OCD patients
(black lines, N = 50) and healthy comparison participants (blue lines, N = 130). (b) Topographies of error-related brain activity for OCD patients, OCD relatives and
healthy comparison participants depicting the mean activity in the time window from 0 to 100 ms after response execution.
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unaffected first-degree relatives of OCD patients showed increased
ERN amplitudes compared to healthy comparison participants.
Second, the increase in ERN magnitude was not specific to
OCD as unaffected first-degree relatives of individuals with anx-
iety disorders were also characterized by increased ERN ampli-
tudes compared to healthy comparison participants. Third,
unaffected first-degree relatives of individuals with SUD showed
reduced ERN amplitudes compared to healthy comparison parti-
cipants, OCD patients, and relatives of individuals with OCD or
anxiety. Overall, these results support the notion that neural
error-signals represent a potential endophenotype not only for
OCD but across different psychiatric disorders.
A useful endophenotype is a robust, state-independent quanti-
tative deviation that is found in patients and unaffected family
members. It is heritable, easy and reliable to assess and inform-
ative about the pathophysiology of the disorder (Gottesman and
Gould, 2003; Miller and Rockstroh, 2013). Enhanced neural error-
signals in OCD fulfill most of these criteria. The ERN has been
shown to have good psychometric properties including validity
and reliability (Olvet and Hajcak, 2009; Weinberg and Hajcak,
2011; Riesel et al., 2013). Increased neural error-signals are
robustly associated with OCD (Endrass and Ullsperger, 2014;
Gillan et al., 2017) and can also be found in unaffected first-
degree relatives of OCD patients (Riesel et al., 2011; Carrasco
et al., 2013). Further, elevated ERN amplitudes in OCD persist
after symptom reduction due to CBT (Hajcak et al., 2008;
Huyser et al., 2011; Riesel et al., 2015). A twin study suggested
a heritability of about 50% for ERN (Anokhin et al., 2008) and
we derived comparable heritability estimates ranging between
22% and 48% (online Supplementary information SI 5).
Altogether, these results highlight that increased neural error-
signals represent a promising endophenotype for OCD.
The current study indicates that increased ERN amplitudes are
also found in healthy participants at familial risk for anxiety (i.e.
unaffected first-degree relatives of individuals with anxiety disor-
ders). This is consistent with studies reporting increased ERN
amplitudes for several anxiety disorders including GAD, social
anxiety, and health anxiety (Manoach and Agam, 2013; Gillan
Table 2. Regression model for the ERN to examine effects of family history on error processing in unaffected comparison participants
Variables R2 F df1, df2 p-value B s.e. β t-value p value
DV: ERN 0.03 0.70 5, 124 0.62
Age 0.06 0.04 −0.03 −0.35 0.11
Gender −0.29 0.83 0.14 1.60 0.73
Obsessive-compulsive inventory-R −0.08 0.11 −0.07 −0.75 0.46
Beck depression inventory-II −0.01 0.16 0.009 −0.08 0.74
State-trait-anxiety-inventory trait 0.06 0.07 0.10 0.77 0.44
DV: ERN 0.13 2.29 8, 121 0.03
Age 0.06 0.04 0.12 1.40 0.16
Gender −0.27 0.80 −0.03 −0.34 0.74
Obsessive-compulsive inventory-R −0.06 0.11 −0.05 −0.56 0.58
Beck depression inventory-II −0.01 0.16 −0.01 −0.09 0.93
State-trait-anxiety-inventory trait 0.05 0.07 0.07 0.65 0.52
Risk for SUD 2.37 1.01 0.21 2.35 0.02
Risk for anxiety −2.94 1.06 −0.26 −2.77 0.007
Risk for depression 0.57 1.10 0.05 0.52 0.61
DV: ERN 0.13 1.86 11, 118 0.05
Age 0.06 0.04 0.13 1.48 0.14
Gender −0.27 0.81 −0.03 −0.33 0.75
Obsessive-compulsive inventory-R −0.07 0.11 −0.06 −0.66 0.51
Beck depression inventory-II −0.05 0.17 −0.04 −0.29 0.78
State-trait-anxiety-inventory trait 0.06 0.07 0.10 0.80 0.43
Risk for SUD 2.77 1.32 0.25 2.11 0.04
Risk for anxiety −3.09 1.38 −0.33 −2.67 0.009
Risk for depression 1.41 1.70 0.13 0.83 0.41
Interaction risk for SUD × risk for anxiety 2.97 2.78 0.15 1.07 0.29
Interaction risk for SUD × risk for depression −3.09 2.50 −0.20 −1.23 0.22
Interaction risk for anxiety × risk for depression 0.29 2.43 0.02 0.12 0.91
DV, dependent variable; SUD, substance use disorders.
Significant values are printed in bold.
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et al., 2017; Riesel et al., 2017). These disorders are frequently
comorbid and share symptoms that have been linked to elevated
neural error signals such as repetitive behavior (Manoach and
Agam, 2013), worry (Moser et al., 2013), and anxiety-proneness
(Cavanagh and Shackman, 2014) pointing to shared pathophysio-
logical mechanisms. The observed increase in ERN in unaffected
relatives with a family history for anxiety disorders or OCD com-
pared to healthy controls provides important evidence for the
assumption that increased neural error-signals represent a trans-
diagnostic endophenotype indicating a shared vulnerability for
OCD and anxiety. This is further supported by results indicating
the state-independence of increased ERN amplitudes not only in
OCD (Hajcak et al., 2008; Huyser et al., 2011; Riesel et al., 2015)
but also in social anxiety disorder (Kujawa et al., 2016). Finally,
increased ERN amplitudes prospectively predict the development
of anxiety symptoms (Lahat et al., 2014; Lamm et al., 2014; Meyer
et al., 2015; Meyer et al., 2018) highlighting the predictive validity
of neural error signals.
The current study did not find support for altered ERN ampli-
tudes in unaffected first-degree relatives of individuals with
depression (i.e. healthy individuals at familial risk for depression).
Results regarding increased ERN amplitudes in depression are
inconsistent (Gillan et al., 2017), pointing toward increases (e.g.
Chiu and Deldin, 2007), as well as decreases (e.g. Weinberg
et al., 2016), or no differences (e.g. Schoenberg, 2014). Overall,
neural error-signals in depression seem to be more affected by
symptom state and severity (Schrijvers et al., 2009), as well as sub-
type (Weinberg et al., 2016). An increase was reported for mild to
moderate depression, but not in severely depressed patients with
melancholic or anhedonic features that even showed a blunted
response to errors (Schrijvers et al., 2009; Weinberg et al.,
2016). Further, alterations in error-monitoring disappear after
symptom reduction (Schrijvers et al., 2009). Together with our
results showing normal error-monitoring in individuals at familial
risk for depression this suggests that ERN alterations seem not to
be an endophenotypic trait marker of depression. Observed
Fig. 2. (a) Grand average waveforms at electrode site FCz for ERN amplitude in healthy comparison participants without a family history for a major psychiatric
disorder (gray line) compared to unaffected first-degree relatives of patients with OCD and OCD patients (first column), unaffected first-degree relatives of indi-
viduals with anxiety disorders (second column), unaffected first-degree relatives of individuals with depression (third column), and unaffected first-degree relatives
of individuals with SUD (last column). (b) Bar chart depicting ERN amplitudes for healthy comparison participants, OCD patients, and unaffected first-degree rela-
tives. Values are means, with error bars depicting standard errors.
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alterations may rather reflect a state marker or a result from over-
lap/comorbidity with relevant transdiagnostic phenotypes. This
supports some specificity and suggests that increased neural error-
signals may distinguish vulnerability for OCD and anxiety from
depression.
Finally, unaffected first-degree relatives of individuals with
SUD showed reduced error-related brain activity compared to
healthy participants without a family history for SUD. This sup-
ports that a blunted neural response to errors may not only be
found in patients with SUD (Luijten et al., 2014; Gillan et al.,
2017) but can also be seen in individuals at increased risk for
SUD. This confirms a previous study in adolescents at high-risk
for SUD that were characterized by diminished neural error-
signals (Euser et al., 2013). Further, the suitability of reduced
error-related brain activity as an endophenotype for SUD is sup-
ported by longitudinal studies showing that it predicts relapse
(Luo et al., 2013; Marhe et al., 2013) and the initiation of tobacco
use (Anokhin and Golosheykin, 2015). Besides SUD, several stud-
ies suggest that reduced ERN amplitudes are also found in schizo-
phrenia (Martin et al., 2018), bipolar disorder (Minzenberg et al.,
2014), and inconsistently in autism and attention-deficit/hyper-
activity disorder (Manoach and Agam, 2013; Luijten et al.,
2014; Gillan et al., 2017). This suggests that a blunted neural
response to errors is common to different disorders and may
reflect a shared pathophysiological mechanism.
In summary, the present results support the utility of neural
error-signals as a dimensional, transdiagnostic endophenotype
with an enhancement in ERN reflecting vulnerability for OCD
and anxiety, and a reduction indicating risk for SUD. OCD and
anxiety disorders are frequently comorbid (Ruscio et al., 2010)
and share prominent clinical features such as heightened harm
avoidance (Kampman et al., 2014), worry (Yook et al., 2010;
Dar et al., 2015), increased intolerance of uncertainty (Tolin
et al., 2003; Holaway et al., 2006), as well as reassurance seeking
and checking behavior (Kobori and Salkovskis, 2013; Weinberg
et al., 2015b; Halldorsson and Salkovskis, 2017). These symptoms
have also been related to hyperactive neural error signals that are
observed across OCD and anxiety disorders (e.g. Moser et al.,
2013; Cavanagh and Shackman, 2014; Weinberg et al., 2015b).
Collectively, similarities in symptoms, neural substrate, and
comorbidity point to a partly shared etiology involving alterations
in error-monitoring. More specifically, differences in neural error
signals that are generated by the ACC (Debener et al., 2005;
Manoach and Agam, 2013; Grutzmann et al., 2016), are assumed
to trigger adaptations in cognition, affect, and control implemen-
tation to avoid future negative outcomes (Shackman et al., 2011;
Cavanagh and Shackman, 2014). In this regard, hyperactive
neural error-signals (i.e. increased sensitivity to errors) in OCD
and anxiety may reflect over-controlled responses and an error-
and harm-avoidant response style. Moreover, elevated neural
error-signals are not only found in patients with these disorders
but seem to indicate vulnerability for OCD and anxiety that per-
sists independent of symptom status and are present in indivi-
duals at risk. On the other hand, reduced neural error-signals
may indicate under-controlled behavior (i.e. reduced responsive-
ness to errors/negative consequences and deficits in adaptive con-
trol) and seem to be related to risk for substance use. Overall, our
results add to numerous findings pointing to common etiological
factors shared between different psychiatric disorders which
encompass structural abnormalities in ACC and disruptions in
cognitive control (Goodkind et al., 2015; McTeague et al.,
2017). Error-monitoring dysfunctions fit nicely into this picture
since they have been linked to cognitive control (Cavanagh and
Shackman, 2014) and are assumed to depend on activity in the
ACC (Debener et al., 2005; Manoach and Agam, 2013). The
ACC is implicated in the processing and integration of negative
affect, cognitive conflict, and pain, as well as the implementation
of adaptive control (Shackman et al., 2011) and its function seems
to be critically involved in mental health.
Some limitations have to be noted. Groups differ in age, how-
ever, results are corrected for age differences. Some patients were
medicated and some had current comorbid disorders. But in line
with previous reports, our findings were not affected by medica-
tion or comorbidity in patients (Stern et al., 2010; Riesel et al.,
2015). Family history methods have high specificity (above 0.9),
but rather low sensitivity and false negative diagnoses are com-
mon (Rougemont-Buecking et al., 2008; Vandeleur et al., 2008;
Vandeleur et al., 2015). This may have led to an underestimation
of family history for depression, SUD, and anxiety. Further, in the
current study diagnostic confidence differs between unaffected
first-degree relatives of OCD patients and unaffected first-degree
relatives of individuals with disorders other than OCD. All
unaffected first-degree relatives of patients with OCD were
recruited via patients of the outpatient clinic for OCD at
Humboldt-Universität zu Berlin, where they were carefully diag-
nosed using the SCID. Thus, the OCD diagnosis of the affected
first-degree relative was verified by a direct SCID. Family history
information for disorders other than OCD was assessed with a
family history interview (Weissman et al., 2000). Due to restric-
tions by data protection regulations, diagnostic information was
not verified with a direct interview of the affected family member.
Further, prevalence rates were too small to separately analyze the
effects of specific anxiety disorders. Finally, the endophenotype
concept is not without criticism (Kendler and Neale, 2010;
Miller and Rockstroh, 2013; Iacono et al., 2017). The success of
the endophenotype strategy to identify predisposing genes has
been demonstrated in non-psychiatric disorders, such as cardiac
syndromes (Keating et al., 1991; Vincent et al., 1992; Keating
and Sanguinetti, 2001), but remains limited for psychiatric disor-
ders (Iacono et al., 2017). The genetic basis of endophenotypes is
complex (Iacono et al., 2017). For the ERN results regarding its
genetic foundation are inconsistent, rely on rather small samples,
and replications are needed (Manoach and Agam, 2013).
Furthermore, as Kendler and Neale (2010) have noted, endophe-
notypes can either causally mediate between genes and the clinical
phenotype, or be risk-indicators that share genes with the pheno-
type. Nevertheless, even complex endophenotypes are presumably
simpler than the complex disorder. Besides pointing out genetic
influences, endophenotypes can help to illuminate disorder
mechanisms and familial environmental risk factors (Kendler
and Neale, 2010) and potentially provide targets for interventions.
Further, endophenotypes and especially profiles of different
potential endophenotypes have the power to differentiate disor-
ders that overlap symptomatically and in pathophysiological
mechanisms, as has been shown for psychotic disorders including
schizophrenia, bipolar, and schizoaffective disorder (e.g. Benes,
2007; Braff and Tamminga, 2017; Ivleva et al., 2017). Thus,
they may inform new ways of categorizing disorders (Insel
et al., 2010) and can foster individualized and precision medicine
(Insel and Cuthbert, 2015). Finally, the clinical relevance of neural
error-signals as a risk indicator or endophenotype is further sup-
ported by studies demonstrating the predictive validity for the
onset of disorders or symptoms (Lahat et al., 2014; Lamm
et al., 2014; Anokhin and Golosheykin, 2015; Meyer et al., 2015,
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2018; Kessel et al., 2016), as well as treatment outcome (Luo et al.,
2013; Marhe et al., 2013) across different mental disorders.
The current study is the first to examine error-monitoring in
unaffected individuals with familial risk for several disorders
simultaneously. A diagnosis of OCD, familial risk for OCD or
anxiety disorders were associated with increased error-related
brain activity compared to healthy control participants without
a family history for psychopathology. In contrast, familial risk
for SUD was associated with a reduced neural response to errors
compared to the healthy control group as well as patients with
OCD and relatives with a family history of OCD or anxiety.
The results provide important evidence for variations in neural
error-signals being a promising transdiagnostic endophenotype
reflecting vulnerability for the development of OCD, anxiety, or
SUD. Further, they add to results suggesting that structural
ACC alterations and deficits in cognitive control represent a
shared neurobiological substrate across mental disorders.
Notes
1 A smaller negative component, the correct-related negativity (CRN, Ford,
1999), can be seen following correct responses. Similarities in topography, tim-
ing, and source suggest that both components reflect similar and overlapping
neuronal and cognitive processes (Vidal et al., 2000; Hoffmann & Falkenstein,
2010; Klawohn et al., 2014). Overall, anxiety and OCD have more closely and
consistently been related to hyperactive error-monitoring. The primary focus
of the present paper is on the ERN and related CRN results are presented
in the online Supplementary information (SI 1).
2 Number of healthy control participants with a family history for other dis-
order: schizophrenia (n = 1), bipolar disorder (n = 3), attention-deficit/hyper-
activity disorder (n = 7), anorexia nervosa (n = 3), tic disorder (n = 1),
excoriation disorder (n = 2), and body dysmorphic disorder (n = 3).
Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S0033291719000199.
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